Daniel J Kingsbury
Overview
Explore the profile of Daniel J Kingsbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brunner H, Schulert G, Sproles A, Thornton S, Cornejo G, Anton J, et al.
Arthritis Res Ther
. 2024 Aug;
26(1):154.
PMID: 39217348
No abstract available.
2.
Brunner H, Schulert G, Sproles A, Thornton S, Cornejo G, Anton J, et al.
Arthritis Res Ther
. 2024 Jun;
26(1):125.
PMID: 38918871
Background: Juvenile idiopathic arthritis (JIA) comprises a heterogeneous group of conditions that can cause marked disability and diminished quality of life. Data on predictors of clinical response are insufficient to...
3.
Brunner H, Tzaribachev N, Louw I, Calvo Penades I, Avila-Zapata F, Horneff G, et al.
Arthritis Care Res (Hoboken)
. 2023 May;
75(11):2259-2266.
PMID: 37221146
Objective: To investigate the frequency and trajectories of individual patients with polyarticular-course juvenile idiopathic arthritis (JIA) achieving novel composite end points on abatacept. Methods: Data from a clinical trial of...
4.
Ruperto N, Brunner H, Synoverska O, Ting T, Abud Mendoza C, Spindler A, et al.
Lancet
. 2021 Nov;
398(10315):1984-1996.
PMID: 34767764
Background: Tofacitinib is an oral Janus kinase inhibitor. This trial assessed the efficacy and safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic arthritis (JIA). Methods: This...
5.
Ruperto N, Brunner H, Pacheco-Tena C, Louw I, Vega-Cornejo G, Spindler A, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(10):4495-4507.
PMID: 33493312
Objectives: To assess efficacy, pharmacokinetics (PK) and safety of intravenous (i.v.) golimumab in patients with polyarticular-course JIA (pc-JIA). Methods: Children aged 2 to <18 years with active pc-JIA despite MTX...
6.
Brunner H, Schanberg L, Kimura Y, Dennos A, Co D, Colbert R, et al.
Arthritis Rheumatol
. 2020 Jun;
72(11):1945-1951.
PMID: 32524767
Objective: To document the need for additional Food and Drug Administration (FDA)-approved medications for the treatment of juvenile idiopathic arthritis (JIA). Methods: The electronic medical records of JIA patients treated...
7.
Chun C, Kingsbury D
Perm J
. 2020 Jan;
23.
PMID: 31926573
Poststreptococcal reactive arthritis (PSRA) is associated with prior group A β-hemolytic streptococcal infection and has a reported annual incidence of 1 to 2 cases per 100,000 persons, approximately twice that...
8.
de Jesus A, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, et al.
J Clin Invest
. 2019 Dec;
130(4):1669-1682.
PMID: 31874111
BACKGROUNDUndifferentiated systemic autoinflammatory diseases (USAIDs) present diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine dysregulation may identify diseases with available targeted treatments.METHODSSixty-six consecutively referred USAID patients underwent underwent...
9.
Saper V, Chen G, Deutsch G, Guillerman R, Birgmeier J, Jagadeesh K, et al.
Ann Rheum Dis
. 2019 Sep;
78(12):1722-1731.
PMID: 31562126
Objective: To investigate the characteristics and risk factors of a novel parenchymal lung disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods: In a multicentre retrospective study, 61...
10.
Brunner H, Nanda K, Toth M, Foeldvari I, Bohnsack J, Milojevic D, et al.
Arthritis Care Res (Hoboken)
. 2019 Aug;
72(10):1420-1430.
PMID: 31421019
Objective: To evaluate safety and effectiveness of adalimumab (ADA) in polyarticular-course juvenile idiopathic arthritis (JIA) in the STRIVE registry. Methods: STRIVE enrolled patients with polyarticular-course JIA into 2 arms based...